Annotation Detail for LCT

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| hsa04973 | Carbohydrate digestion and absorption |
| hsa01100 | Metabolic pathways |
| hsa00052 | Galactose metabolism |
| Pathway ID | Pathway Name |
|---|
| Metabolism of carbohydrates |
| Desease ID | Desease Name |
|---|
| Inherited disorders of carbohydrate metabolism |
| H00116 | Congenital lactase deficiency |
| Genetic disorders |
| Desease ID | Desease Name |
|---|
| 1831 | Prostate cancer |
| 2053 | Colon cancer |
| Desease Name |
|---|
| milk intolerance |
| colorectal cancer |
| calcium |
| fractures, nonvertebral |
| Lactose Intolerance |
| adult-type hypolactasia |
| CANCER |
| bone density |
| bone fractures |
| hypolactasia, adult-type |
| METABOLIC |
| Desease Name |
|---|
| Lactase deficiency, congenital |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of LCT mRNA | affects expression | 16483693
|
| C014347 |
decitabine |
decitabine results in increased expression of LCT mRNA | increases expression | 18845559
|
| D005632 |
Fructose |
Fructose results in increased expression of LCT mRNA | increases expression | 11242478
|
| C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of LCT mRNA | decreases expression | 17426115
|
| C058229 |
polydatin |
LCT protein results in increased hydrolysis of polydatin analog | increases hydrolysis | 17009167
|
| D013395 |
Sucrose |
Sucrose results in increased expression of LCT mRNA | increases expression | 11242478
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.47 | 19483382 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.54 | 19208741 18320071 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.66 | 19215824 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.37 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
| MESH:D003327 |
Coronary Disease |
|
Fructose |
4.66 | 18504504 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
4.76 | 18603373 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
3.44 | 18603373 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.64 | 19294695 |
| MESH:D005234 |
Fatty Liver |
|
Fructose |
9.22 | 19196556 18395287 18641190 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
9.22 | 19236843 20131406 |
| MESH:D005355 |
Fibrosis |
|
Fructose |
5.08 | 18504504 |
| MESH:D018149 |
Glucose Intolerance |
|
Fructose |
5.68 | 19165636 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.69 | 19215824 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 19772884 16221962 18467677 19176532 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
| MESH:D006946 |
Hyperinsulinism |
|
Fructose |
5.16 | 18360027 19008412 15752949 14757778 18563319 |
| MESH:D006949 |
Hyperlipidemias |
|
Fructose |
5.10 | 15752949 |
| MESH:D006973 |
Hypertension |
|
Fructose |
3.71 | 19008412 14573337 14568997 14633139 16843071 |
| MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
5.38 | 19342510 19799862 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
3.40 | 17581917 |
| MESH:D007333 |
Insulin Resistance |
|
Fructose |
8.31 | 19586609 14757778 14573337 17133782 18563319 19799862 18057795 19342510 14633139 19008412 18981581 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
8.31 | 16306350 |
| OMIM:223000 |
LACTASE DEFICIENCY, CONGENITAL |
marker/mechanism |
|
| |
| OMIM:223100 |
LACTOSE INTOLERANCE, ADULT TYPE |
marker/mechanism |
|
| |
| MESH:D007938 |
Leukemia |
|
decitabine |
3.21 | 19235587 18980019 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.33 | 19117987 18454857 17236224 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.42 | 18206229 17679729 19387464 18460780 18704418 19010910 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.98 | 18055864 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.91 | 20007298 15890375 16377806 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
3.64 | 19470736 |
| MESH:D008545 |
Melanoma |
|
decitabine |
2.28 | 16505122 17785578 |
| MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
5.09 | 19165636 18497449 16815490 17098227 17261469 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.56 | 18172295 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.54 | 19010910 18608210 19157545 16882708 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
5.48 | 19116145 19470736 17925555 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.48 | 17405874 |
| MESH:D009765 |
Obesity |
|
Fructose |
5.06 | 17707055 18585860 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
5.06 | 20558911 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.72 | 19259094 19331143 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.85 | 19294695 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.15 | 17616702 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.75 | 19155313 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.57 | 17967635 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.82 | 17616700 19087683 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.43 | 17785578 |
PharmGKB Accession:PA30315
| Releated disease ID |
Related disease Name |
| PA145007194 | Congenital lactase deficiency |
| PA444711 | Lactose Intolerance |
| Releated drug ID |
Related drug Name |
| PA450161 | lactose |
| Drugbank ID |
Action |
Drug Name |
Description |
|---|
| DB00126 |
- |
Vitamin C |
Antioxidants;Essential Vitamins;Free Radical Scavengers;Vitamins (Vitamin C);Vitamins |
| DB02376 |
- |
D-Gluconhydroximo-1,5-Lactam |
|
| DB02471 |
- |
Nojirimycine Tetrazole |
|
| DB02944 |
- |
Alpha-D-Mannose |
|
| DB03389 |
- |
Xylopyranose |
|
| DB03965 |
- |
Fucose |
|
| DB04282 |
- |
2-Deoxy-2fluoro-Glucose |
Beta-Glucosidase A Inhibitors |
| DB04564 |
- |
Gluconolactone |
|
| DB04659 |
- |
(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE |
|
| DB04779 |
- |
ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE |
|
| DB08558 |
- |
2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL |
|